Issue 42, 2019

Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours

Abstract

Improved delivery materials are needed to enable siRNA transport across biological barriers, including the blood–brain barrier (BBB), to treat diseases like brain cancer. We engineered bioreducible nanoparticles for systemic siRNA delivery to patient-derived glioblastoma cells in an orthotopic mouse tumor model. We first utilized a newly developed biomimetic in vitro model to evaluate and optimize the performance of the engineered bioreducible nanoparticles at crossing the brain microvascular endothelium. We performed transmission electron microscopy imaging which indicated that the engineered nanoparticles are able to cross the BBB endothelium via a vesicular mechanism. The nanoparticle formulation engineered to best cross the BBB model in vitro led to safe delivery across the BBB to the brain in vivo. The nanoparticles were internalized by human brain cancer cells, released siRNA to the cytosol via environmentally-triggered degradation, and gene silencing was obtained both in vitro and in vivo. This study opens new frontiers for the in vitro evaluation and engineering of nanomedicines for delivery to the brain, and reports a systemically administered biodegradable nanocarrier for oligonucleotide delivery to treat glioma.

Graphical abstract: Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours

Supplementary files

Article information

Article type
Paper
Submitted
05 6 2019
Accepted
09 9 2019
First published
04 10 2019

Nanoscale, 2019,11, 20045-20057

Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours

J. Karlsson, Y. Rui, K. L. Kozielski, A. L. Placone, O. Choi, S. Y. Tzeng, J. Kim, J. J. Keyes, M. I. Bogorad, K. Gabrielson, H. Guerrero-Cazares, A. Quiñones-Hinojosa, P. C. Searson and J. J. Green, Nanoscale, 2019, 11, 20045 DOI: 10.1039/C9NR04795F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements